Trypsin and Chymotrypsin [MAK Value Documentation, 2016]

Trypsin (EC 3.4.21.4) and Chymotrypsin (EC 3.4.21.1) are proteolytic pancreatic enzymes which are secreted as inactive precursors trypsinogen and chymotrypsinogen, respectively. They have several clinical pharmacological as well as laboratory applications and they are used in protein chemistry, especially in the preparation of insulin. Exposure to enzyme dusts has long been known to cause occupational immediate hypersensitivities of the airways. Also trypsin and chymotrypsin are potential inhalable sensitizers; cases of specific airway sensitization caused by trypsin and chymotrypsin containing products could be shown clearly by several studies. Positive skin prick and challenge tests as well as specific IgE antibodies have been described. Since these results and the clinical symptoms usually matched well, an immunological mechanism of action is suggested. There is no clear evidence of allergic cell-mediated late type eczematous skin reactions. Trypsin and chymotrypsin are designated with “Sa” (for substances causing airway sensitization) but not with “Sh” (for skin-sensitizing substances). Keywords: trypsin; chymotrypsin; allergenic effects; occupational exposure; maximum workplace concentration; MAK value; toxicity; hazardous substance

[1]  G. Hur,et al.  Copyright � The Korean Academy of Medical Sciences A Case of Occupational Rhinitis Caused by Porcine Pancreatic Extract Developing into Occupational Asthma , 2007 .

[2]  J. Kleine‐Tebbe,et al.  Multiple IgE‐mediated sensitizations to enzymes after occupational exposure: evaluation by skin prick test, RAST, and immunoblot , 1997, Allergy.

[3]  F. Gyntelberg,et al.  Allergy risk in an enzyme producing plant: a retrospective follow up study. , 1997, Occupational and environmental medicine.

[4]  A. N. Newman Taylor,et al.  Bronchial asthma in a paediatric nurse caused by inhaled pancreatic extracts. , 1991, British journal of industrial medicine.

[5]  B. Leijnse,et al.  Occupational allergy to pancreatic powder: characterization of IgE-binding antigens in pancreatic extract by immunoblotting. , 1991, The Journal of allergy and clinical immunology.

[6]  G. Lipkin,et al.  ALLERGY IN CYSTIC FIBROSIS NURSES TO PANCREATIC EXTRACT , 1987, The Lancet.

[7]  B. Wüthrich,et al.  [Allergic asthma from enzymes in drugs]. , 1984, Schweizerische medizinische Wochenschrift.

[8]  P. Lieberman,et al.  IgE mediated hypersensitivity to pancreatic extract (PE) in parents of cystic fibrosis (CF) children , 1979, Clinical allergy.

[9]  H. Colten,et al.  Immediate hypersensitivity to hog trypsin resulting from industrial exposure. , 1975, The New England journal of medicine.

[10]  L. Criep,et al.  ALLERGY TO TRYPSIN. , 1964, The Journal of allergy.

[11]  B. Erlanger,et al.  Hypersensitivity to purified trypsin and chymotrypsin. , 1961, The New England journal of medicine.

[12]  H. Colten,et al.  Hypersensitivity to pancreatic extracts in parents of patients with cystic fibrosis. , 1977, The Journal of allergy and clinical immunology.

[13]  B. Zweiman,et al.  Inhalation sensitization to trypsin. , 1967, The Journal of allergy.

[14]  F. Aladjem,et al.  Allergy to chymotrypsin. , 1957, The Journal of allergy.